Back

Predictors and Outcomes of Atrial Fibrillation Progression in Patients with Device-Detected Subclinical AF: Insights from the ARTESiA Trial

31 August 2024 (17:54 - 18:06)
Organised by: Logo
Congress Presentation Part of: Smaller trials, trial updates, and other studies: atrial fibrillation detection, prevention and treatment Defining Types of Atrial Fibrillation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Giuseppe Boriani

Modena Polyclinic Modena University Hospital, Modena (Italy)

4 More presentations in this session

Presentation thumbnail
Catheter ablation in persistent atrial fibrillation: long term outcomes of the CAPLA multicentre randomised trial of pulmonary vein isolation(PVI) vs PVI plus posterior left atrial wall isolation(PWI)
Doctor P. Kistler (Melbourne, AU)
Slides Video
Presentation thumbnail
Randomized evaluation of decision support interventions for atrial fibrillation: Anticoagulant adherence after shared decision making interventions for stroke prevention in atrial fibrillation
Professor E. Jackson (Birmingham, US)
Slides Video
Presentation thumbnail
Biomolecule-based prediction of sinus rhythm and interaction with early rhythm control: EAST-AFNET 4 biomolecule study
Professor L. Fabritz (Hamburg, DE)
Slides Video
Presentation thumbnail
The Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation Extend
Doctor A. Tang (London, CA)
Slides Video

Access the full session

Session thumbnail
Smaller trials, trial updates, and other studies: atrial fibrillation detection, prevention and treatment
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 17:54 CET
You may be interested in
thumbnail
Congress Presentation
Progression of device-detected atrial fibrillation to clinical atrial fibrillation: should we worry?
thumbnail
Congress Presentation
Reducing stroke risk in patients with atrial high-rate episodes (AHRE)
thumbnail
Congress Session
Smaller trials, trial updates, and other studies: atrial fibrillation detection, prevention and treatment

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources